Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
16.82
-0.29 (-1.69%)
At close: May 12, 2025, 4:00 PM
16.80
-0.02 (-0.15%)
After-hours: May 12, 2025, 7:59 PM EDT
Oscar Health Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Oscar Health stock have an average target of 20.21, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 20.15% from the current stock price of 16.82.
Analyst Consensus: Hold
* Price targets were last updated on Mar 13, 2025.
Analyst Ratings
The average analyst rating for Oscar Health stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 4 | 3 | 3 | 2 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $20 → $16 | Buy → Hold | Downgrades | $20 → $16 | -4.88% | Mar 13, 2025 |
| Jefferies | Jefferies | Sell Initiates $12 | Sell | Initiates | $12 | -28.66% | Dec 10, 2024 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $21 → $14 | Hold → Sell | Downgrades | $21 → $14 | -19.74% | Nov 6, 2024 |
| UBS | UBS | Hold Initiates $23 | Hold | Initiates | $23 | +36.74% | Oct 7, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $28 | Buy | Reiterates | $28 | +66.47% | Sep 10, 2024 |
Financial Forecast
Revenue This Year
11.40B
from 9.18B
Increased by 24.21%
Revenue Next Year
11.46B
from 11.40B
Increased by 0.55%
EPS This Year
0.74
from 0.10
Increased by 642.05%
EPS Next Year
1.02
from 0.74
Increased by 37.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 11.9B | 13.3B | 15.1B |
| Avg | 11.4B | 11.5B | 13.8B |
| Low | 10.4B | 9.8B | 11.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 29.2% | 16.4% | 32.0% |
| Avg | 24.2% | 0.6% | 20.1% |
| Low | 13.1% | -14.0% | -3.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.92 | 1.94 | 2.49 |
| Avg | 0.74 | 1.02 | 1.82 |
| Low | 0.59 | 0.39 | 1.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 824.0% | 161.8% | 143.1% |
| Avg | 642.1% | 38.0% | 77.7% |
| Low | 488.0% | -47.2% | 13.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.